相关实验视频

Updated: May 12, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

在质母细胞瘤患者中使用树突细胞疫苗 (CombiG-vax) 的第二阶段研究的第一步结果

Laura Ridolfi¹, Lorena Gurrieri¹, Nada Riva¹

¹Experimental and Clinical Oncology of Immunotherapy and Rare Cancers, Biobank Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.

Frontiers in immunology

|August 28, 2024

概括

与标准质母细胞瘤治疗相结合的树突细胞疫苗接种 (DCvax) 是安全的,并且显示出有前途的无进展生存. 这种方法需要在更大的患者队列中进行进一步的研究.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
临床试验临床试验

背景情况:

质母细胞瘤 (GBM) 是一种具有不良预后的4级质母细胞瘤.
标准治疗包括手术,放射治疗 (RT) 和temozolomide (TMZ).
树突细胞疫苗接种 (DCvax) 已显示出在黑色素瘤中增加抗瘤T细胞反应的潜力.

研究的目的:

评估DCvax的安全性和有效性,与切除的GBM的标准治疗相结合.
作为主要终点,评估三个月后的无进展生存期 (PFS).
为了研究DCvax在GBM患者中产生的免疫反应.

主要方法:

一个单臂,单心的第二阶段试验,遵循西蒙的两步设计.
在放射化疗后开始使用DCvax,最初每周服用一次,然后每月交替使用TMZ循环.
主要终点包括三个月后的PFS和安全性;二次终点涉及体外和体内免疫反应评估 (DTH皮肤测试).

主要成果:

试验的第一阶段招募了9名可评估患者.
两名患者在三个月内进展;没有观察到与DCvax相关的G3-4毒性.
五名患者表现出积极的延迟型过敏性 (DTH) 测试,表明免疫反应.

结论:

DCvax与标准的GBM治疗的结合耐受性很好.
该研究满足了第一步的主要终点,支持进入第二步的进展.
计划进一步招募19名患者以证实这些发现.

关键词:

采用细胞疗法采用细胞疗法树突细胞的树突细胞.质母细胞瘤 (glioblastoma) 是一种免疫疗法免疫疗法放射化疗是放射化疗的一种疗法.疫苗疫苗疫苗疫苗

更多相关视频

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...